ArticleCancer discovery2015

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Jianfeng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.